Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Archive
Top Five Countries to Watch for International Cannabis Reform in 2024
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
[Webinar] Identifying International Cannabis Opportunities in Europe
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
Navigating Minnesota’s New Rules for Manufacturers and Sellers of Lower Potency Hemp-Derived Edible Products
By Andrea Golan
Aug 23, 2023
Minnesota's new adult-use cannabis law makes some significant changes to the state's existing rules governing the manufacture and sale of hemp-derived cannabinoid products. Read this article for information on some of the most notable changes, including seller registration requirements, prohibited products, and cannabinoid serving limits.
CBD Products Liability Lawsuits Could Be Revived After FDA Declines to Regulate Cannabidiol
By Catie Wightman
Feb 13, 2023
In recent years, several CBD companies faced product liability lawsuits brought by consumers. Many of these cases were dismissed without prejudice or stayed until the FDA takes action to regulate CBD products. Now that the FDA said it will not take action to regulate CBD, could these cases be revived?
Recommending CBD and Hemp Products for Pets: Legal Considerations for Veterinarians
By Catie Wightman
Feb 9, 2023
With recent announcements from the FDA pushing CBD and hemp-derived products further into a legal gray area, can veterinarians recommend or sell these products for pets?
‘Cannabis Seeds Are Federally Legal: What Now?’ Webinar from Cannabis Business Times Will Feature Shane Pennington
Jan 19, 2023
Join Shane Pennington on February 1 for a Cannabis Business Times webinar discussing the opportunities and challenges surrounding the federally legal cannabis seeds market.
[Webinar] Intoxicating Hemp Regulations: Where We Are and What's to Come
Dec 15, 2022
Watch as Vicente Sederberg LLP and EARTH Law LLC discuss the regulatory approaches for intoxicating hemp in Colorado, Oregon and California, and our projections for the future
Recent FDA Enforcement Letters Signal Increased FDA Scrutiny of Hemp Products
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
Guide for Shipping Hemp and Hemp-Derived CBD Products
By Michelle Bodian, Catie Wightman
Nov 1, 2022
Planning to ship hemp or hemp-derived CBD products? Read this first.
Will the 2023 Farm Bill Address Hemp Industry Pain Points and Public Safety Concerns?
By Andrea Golan
Oct 31, 2022
As Congress considers the next Farm Bill, hemp stakeholders and lawmakers are strongly advocating for reforms that will benefit the industry and consumers.
Lessons Learned from the Regulation of CBD Products in the United Kingdom
By Shawn Hauser, Catie Wightman, Ariane Beckman
Sep 20, 2022
Like the US, regulators in the UK are struggling to find ways to best regulate CBD and other hemp-derived products—frustrating hemp businesses across the globe. Read this VS Insights article to learn how the UK is currently regulating CBD and key findings and recommendations from the ACMD's Consumer CBD Products Report.
Is CBD Safe? Health Canada Report Weighs In
By Ariane Beckman, David Kramer
Aug 23, 2022
Health Canada recently released a report titled, “Review of cannabidiol: Report of the Science Advisory Committee on Health Products Containing Cannabis.” Learn about the findings in this VS Insights article.
FDA Enforcement Continues Against Companies Making CBD Product Claims
By Catie Wightman, Ariane Beckman
Aug 11, 2022
The FDA is cracking down on companies making unlawful drug or disease claims about their products relating to CBD by recently issuing several warning letters to address these compliance violations.
Vicente Sederberg LLP Hemp Update: July 2022
Jul 28, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
Shawn Hauser Speaks With Members of UK Parliament About the Benefits of Cannabis Legalization
Jun 29, 2022
VS partner Shawn Hauser visited the Palace of Westminster in London on June 29th to speak with members of Parliament about the economic benefits and lessons learned from cannabis legalization in Colorado and other states.
HIA v DEA Lawsuit: The Hemp Industry Needs Your Support to End DEA Overreach
Apr 14, 2022
Update on the lawsuit HIA & RE Botanicals, Inc v. DEA and why this case is critical to the hemp industry's future.
Vicente Sederberg LLP Hemp Update: April 2022
Apr 4, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
[Webinar] Minor Cannabinoids & Trending Topics in Hemp
Apr 1, 2022
Watch this session exploring trending topics in hemp. During the session, members of our hemp team dive into the legality, regulation, and lawsuits surrounding minor cannabinoids, current federal hemp legislation, and what we expect and hope to see in the 2023 Farm Bill.
FDA Warns CBD Companies Making COVID-19 Claims: 7 Key Takeaways from the Latest CBD Product Warning Letters
By Michelle Bodian, Jace Pohlman
Mar 30, 2022
The FDA and FTC are working together to target fraudulent COVID-19 claims made by CBD companies. Seven CBD product companies received warning letters. Read this article for a look into what to do—or not do—to avoid a warning.
USPS Bans Mailing Hemp and CBD Vape Products to Consumers
By Andrea Golan, Jace Pohlman
Nov 3, 2021
USPS Final Rule bans e-cigarettes and all vaping products, including those containing hemp-derived ingredients unless a business-to-business or regulatory exception is met.
What is the FDA saying about Full Spectrum Hemp? Key Takeaways from Rejections of NDINs
By Shawn Hauser
Aug 25, 2021
Recent NDIN notification objections from the FDA give us more insight into the agency's factors differentiating "full spectrum" hemp from CBD.
Michelle Bodian Featured in INCBA CLE: Hemp 301
Aug 20, 2021
VS attorney Michelle Bodian discusses the hemp industry's environmental challenges and opportunities in this on-demand CLE from the INCBA
Andrea Golan Featured in INCBA CLE: Hemp 201 — FDA and the Marketing of CBD Products
Aug 11, 2021
With a new Administration and Congress, changes in personnel at FDA, and new safety data being published, is 2021 the year when CBD will come out from under the FDA shadows to be legally marketed in all 50 states?
Shawn Hauser to Provide Hemp and CBD Insights During SupplySide Network 365 Education Series Workshop
Aug 2, 2021
VS partner Shawn Hauser will discuss hemp and cannabinoids during a SupplySide Network 365 Education Series workshop with Natural Products Insider on August 19, 2021.
Understanding the Shifting Trends of State and Federal CBD Laws and Regulations
By Shawn Hauser
Jul 22, 2021
In this article, we’ll look at the history of CBD regulation in the United States, the trends that are dominating CBD regulation in 2021, and some of the state-specific regulations in the largest states.
Federal and State Overview: Regulation of Products Containing 'Minor' Hemp-Derived Cannabinoids
By Catie Wightman, Jace Pohlman
Jul 13, 2021
Move over CBD; there are new cannabinoids in town. CBD has been the most sought-after and utilized hemp-derived cannabinoid in consumer products, but due in part to technological advances, various other hemp-derived cannabinoids, like CBG, CBN, and CBC, are now creating a well-deserved buzz.
New Hemp CBD Laws, Regulations, and Policies: June 2021 Update
By Caitlin Wightman, Michelle Bodian, Jace Pohlman
Jun 15, 2021
Over the first half of 2021, many states passed laws, implemented, or proposed new regulations regarding hemp cultivation, processing, and CBD products. These changes range from updates to testing, labeling, and packaging requirements, to adjustments in license requirements and limits on the types of hemp-derived products that can be sold.
Memo to the INCB Regarding Draft Guidelines on Control Requirements for Medical and Scientific Cannabis
By Vicente Sederberg LLP
May 24, 2021
Read the memo VS delivered to the International Narcotics Control Board, which gives draft guidelines on control requirements for medical and scientific cannabis and discusses the implications and important issues for consideration.
Shawn Hauser to Speak About Hemp CBD at CRN Legal, Regulatory, and Compliance Forum on Dietary Supplements
May 7, 2021
Shawn will discuss the path forward for hemp-derived CBD at the Council for Responsible Nutrition's June 8-10 event.
5 Things You Need to Know Before Entering the Cannabis Industry
By Brian Vicente
Apr 19, 2021
The cannabis industry is complex. Prospective cannabis business owners and other service providers interested in working with cannabis businesses are wise to take a step back and assess what it really takes to not only enter the cannabis industry, but to succeed in it.
Seven Regulatory-related Factors for Marijuana Companies to Consider in a Debt Transaction
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
5 Key Takeaways from the FTC CBDeceit Crackdown on CBD Businesses
By Caitlin Wightman, Michelle Bodian
Dec 23, 2020
On December 17, 2020, the Federal Trade Commission announced robust enforcement actions against companies making deceptive claims about CBD and CBG products.
The Cannabis Business: Understanding Law, Finance, and Governance in America's Newest Industry
By Vicente Sederberg LLP
Dec 18, 2020
Vicente Sederberg attorneys wrote the book on cannabis law — and now you can own it! This comprehensive primer on all things cannabis law is a must-have for anyone seeking to understand the major practical legal issues facing the marijuana and hemp industries.
Memo to the INCB
By Vicente Sederberg LLP
Dec 1, 2020
Read the memo VS delivered to the International Narcotics Control Board, which contests current international controls of CBD preparations and discusses the potential impacts of reform.
Selling CBD Products Online? State Retailer Registration Requirements May Apply
By Catie Wightman
Nov 16, 2020
If you are selling CBD products—even products sold exclusively online—you must follow retailer requirements in the states where you sell products (i.e., where your customers are located).
New York Releases Proposed Hemp Cannabinoid Regulations
By Michelle Bodian
Oct 29, 2020
New York State Department of Health published draft regulations for the processing and retail sale of cannabinoid hemp.
Raising Private Capital in the Cannabis Industry
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.
Prop 65 Warning Requirements for Cannabis, THC and CBD
By Andrea A. Golan
Apr 13, 2020
In early 2020, California’s Office of Environmental Health Hazard Assessment added Δ9 THC and marijuana smoke to the Proposition 65 list of chemicals known as reproductive toxins. What does this mean for cannabis businesses?
Hemp Coalition Releases Additional Hemp Policy Recommendations
Mar 24, 2020
A coalition of hemp industry stakeholders, including Vicente Sederberg LLP, released a second set of new policy recommendations for officials developing federally compliant state hemp programs.
Protecting Your CBD Business from Product Liability Lawsuits
By Michelle Bodian
Mar 9, 2020
With any new consumer product craze, lawsuits will inevitably follow. The hemp-CBD industry is no exception. The current wave of CBD-related lawsuits has primarily been product liability claims.
Hemp Coalition Releases New Hemp Policy Recommendations & Updated Model Plan
Feb 27, 2020
A coalition of hemp industry stakeholders, including Vicente Sederberg LLP, released new policy recommendations and an updated model plan for state hemp programs.
What You Need to Know About the FDA Consumer Update on CBD
By Shawn Hauser, Partner; Corey Cox, Associate Attorney
Nov 27, 2019
The FDA issued an update on November 25, 2019, reiterating its position on CBD products in food and dietary supplements. What does this mean for your business?
Reflections on the 2018 Farm Bill
By Michelle Bodian, Senior Associate Attorney and Caitlin Wightman, Law Clerk
Jul 17, 2019
Since the passage of the 2018 Farm Bill on December 20, 2018, much has changed in the world of hemp. Here's a recap of major hemp-related developments.